Webinar Q&A follow-up: Manipulation of Abuse Deterrent Formulations at the Clinical Pharmacology Unit

On the 8th June we featured a fantastic live webinar from Scott Smiley (Vince & Associates Clinical Research, an Altasciences company), discussing the development of abuse deterrent formulations (ADFs) as a strategy to help combat the growing opioid epidemic in the USA and worldwide. We learnt more about the need for ADFs, strategies of opioid abuse and abuse prevention as well as the factors that must be taken into account for successful in vivo studies. We’ve compiled the Q&A section below, including those questions we didn’t have time to answer in the live session, for you to take a look...

To view the full article, please register now for access

It's completely free